9
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Literature Alerts

Pages 263-272 | Published online: 26 Jun 2009

LITERATURE ALERTS

  • A simple and low cost method for fabricating single crystal microspheres. WEN, W., and Lu, K., J. Cryst. Growth, 1996, 165 (1/2), 191–194.
  • A bacteria-expressed mouse interleukin-1 receptor antagonist peptide protects alginate-poly-L-lysine-alginate microencapsulated rat islets against the suppressive effect of inter-leukin-l.beta. in vitro. Hsu, B. R. S., CHANG, F. H., Fu, S. H., HUANG, Y. Y., JUANG, J.H., and HUANG, H. S., Transplant Proc., 1996, 28 (3), 1961–1963.
  • A homogeneous time-resolved fluoroimmunoassay for haptens utilizing liposomes. lus, A., BACIGALUPO, M. A., and MESON, G., Anal. Biochem., 1996, 238 (2), 208–211.
  • A method to attach lectins to the surface of spermine/alginate microcapsules based on the avidin biotin interaction. SULTZBAUGH, K. J., and SPEAKER, T. J., y. micraencapneratian, 1996, 13 (4), 363–376.
  • A month-long effect from a single injection of microencapsulated human growth hormone. JOHNSON, 0. L., CLELAND, J. L., LEE, H. J., CHARNIS, M., DUENAS, E., JAwoRowicz, W., SHEPARD, D., SHAHZAMANI, A., JONES, A. J., and PUTNEY, S. D., Nat. Med., 1996, 2 (7), 795–799.
  • A novel method of preparing PLGA microcapsules utilizing methylethyl ketone. SAH, H., SMITH, M. S., and CHERN, R. T., Pharm. Res., 1996, 13 (3), 360–367.
  • A survey of microencapsulation processes. THIES, C., Drugs Pharm. Sci., 1996, 73 (Microen-capsulation), 1–19.
  • Activity of urease immobilized in liposomes containing metal ions. VELINOV, 0., NEITCHEV, V., DIMKOV, R., and TOPALOVA, Y., Dokl. Bulg. Akad. Nauk., 1995, 48 (11-12), 111–114.
  • Aerosolization and hygroscopic growth evaluation of lyophilized liposome aerosols under controlled temperature and relative humidity conditions. JoHNsoN, D. L., WENGER, E. N., and POLIKANDRITOU, L. M., Aerosol. Sci. Technol., 1996, 25 (1), 22–30.
  • Alterations in the binding of fluorescent probes 1-anilinonaphthalene-8-sulfonate and 4-(4-dimethylaminostyry1)-1-methylpyridinium 4-toluenesulfonate to liposomes upon ir-radiation. GORBENKO, G. P., Biofizika, 1996, 41(2), 363–368.
  • Amphiphilic helical peptides sensing the curvature of phospholipid liposomes. ZHAO, J., KIMURA, S., and ImANism, Y., J. Colloid Interface Sci., 1996, 181 (1), 252–258.
  • An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation. GOKHALE, P. C., RADHAKRISHNAN, B., HUSAIN, S. R., ABERNETHY, D. R., SACHER, R., DRITSCHILO, A., and RAHMAN, A., Br. J. cancer, 1996, 74 (1), 43–48.
  • An investigation of the synthesis of poly(DL-lactic acid) and preparation of microspheres containing indomethacin. GOHEL, M. C., PATEL, M. M., KAUL, J. S., PATEL, R. B., PATEL, S. R., and JANI, T. R., Drug Dev. Ind. Pharm., 1996, 22 (7), 637–643.
  • Anti-pseudomonal activity of collagen sponge with liposomal polymptin B. TRAFNY, E. A., GRZYBOWSK/, J., OLSZOWSKA, G. M., ANTOS, TV., and STRUZYNA, J., Pharmacol. Res., 1996, 33 (1), 63–65.
  • Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro. ANTOS, M., TRAFNY, E. A., and GRZYBOWSKI, J., Pharmacol. Res., 1995, 32 (1-2), 85–87.
  • Antifreeze glycoproteins inhibit leakage from liposomes during thermotropic phase transi-tions. HAYS, L. M., FEENEY, R. E., CROWE, L. M., CROWE, J. H., and OLIVER, A. E., Proc. Natl. Acad. Sci. USA, 1996, 93 (13), 6835–6840.
  • Antitumor effect of mitroxantrone-loaded bovine casein microspheres on Ehrlich ascites carcinoma in mice. LATHA, M. S., LATHA, P. G., SUBRAMONIAM, A., and JAYAKRISHNAN, A., Drug Delivery, 1996, 3 (2), 75–79.
  • Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and proparnidine. VAN ROOIJEN, N., SANDERS, A., and VAN DEN BERG, T. K., J. Immunol. Methods, 1996, 193 (1), 93–99.
  • Application of liposomes in antigen presentation and cytokine delivery. DONG, P., and Ho, J. Y. R., J. Liposome Res., 1996, 6 (2), 305–323.
  • Application of surface chemistry in pharmaceuticals. 7. Design and development of lipo-somes for use in therapeutics. HIROTA, D., and SADZUKA, Y., Pharm. Tech. jpn., 1996, 12 (7), 925–931.
  • Application of liposomes to textile dyeing and finishing. TAKAGISHI, T., and Kim, I. S., Senshoku Kogyo, 1996, 44 (6), 252–262.
  • Augmentation of macrophage function in vivo with liposome mediated interleukin-2 gene therapy. WANG, Q., CAO, X., ZHANG, W., WANG, J., Xu, Z., and YE, T., Zhonghua Weishengwuxue He Mianyixue Zazhi, 1996, 16 (1), 58–62.
  • Beneficial effects of additional adjuvants on the immune response to haptenated liposomes. VERHEUL, A. F. M., GOLDING, B., INMAN, J. K., and SNIPPE, H., J. Liposome Res., 1996, 6 (2), 397–414.
  • Biodegradable microcapsules: optimization of formulation using factorial design. MANDAL, T. K., and TENJARLA, S., Pharm. Sci., 1995, 1(8), 367–370.
  • Biodegradable polymer microspheres containing a steroidal anti-androgen, 17 a-acetoxy-6-chloro-2-oxa-4,6-pregnadiene-3, 20-dione (TZP-4238), for local atrophic therapy of rat prostate. OKABE, D., KOBAYASHI, D., ONO, Y., MASHIMO, T., YUASA, H., YAMANAKA, H., ASANO, M., OMICHI, H., and YOSHIDA, M., Pharm. Sci., 1995, 1(7), 307–309.
  • Biodegradable microspheres: advances in production technology. BENOIT, J. P., MARCHAIS, H., ROLLAND, H., and VELDE, V. V., Drugs Pharm. Sci., 1996, 73 (Microencapsulation), 35–72.
  • Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suitable' approach. BUITING, A. M. J., ZHOU, F., BARKER, J. A. J., VAN ROOIJEN, N., and HUANG, L., J. Immunol. Methods, 1996, 192 (1-2), 55–62.
  • Biological characterization of L-asparaginase liposomal formulations. GASPAR, M. M., PEREZ, S. R., and CRUZ, M. E., Cancer Chemother. Pharmacol., 1996, 38 (4), 373–377.
  • Blood-pool imaging using technetium-99m-labeled liposomes. GOINS, B., PHILLIPS, W. T., and KLIPPER, R., I. Nucl. Med., 1996, 37 (8), 1374–1379.
  • Cationic liposomes enhance retrovirus-mediated multinucleated cell formation and retro-viral transduction. KANEKO, Y., and TSUKAMOTO, A., Cancer Lett., 1996, 105 (1), 39–44.
  • Characterization of liposomal systems entrapping boron-containing compounds in response to pH gradients. MORAES, A. M., SANTANA, M. H. A., and CARBONELL, R. G., Biofunct. Membr., (Proc. Int. Conf.), Plenum, New York, N. Y., 1996, 259–275.
  • Characterization of the intermediate products of lipid peroxidation in phosphatidylcholine liposomes by fast-atom bombardment mass spectrometry and tandem mass spectro-metry techniques. FACINO, R. M., CARINI, M., ALDINI, G., and CoLomeo, L., Rapid Commun. Mass. Spectrom, 1996, 10 (9), 1148–1152.
  • Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. FILIPOVIC, G. J., BECIREVIC, L. M., SKALKO, N., and JALSENJAK, I., Int. J. Pharm., 1996, 135 (1,2), 183–190.
  • Chronokinetics of liposomal encapsulated ampicillin in fasting and nonfasting rats. PARDUE, R. L., and WHITE, C. A., J. Pharm. Sci., 1996, 85 (3), 309–312.
  • Competitive binding of fluorescent probe 4-(p-dimethylaminostyry1)-1-methylpyridinium p-toluenesulfonate and lysozyme to liposomes. GORBENKO, G. P., Biofizika, 1996, 41(2), 355–362.
  • Contribution of different sites of the binding subunit of the plant toxin ricin in its interaction with liposomes. TONEVITSKY, A. G., AGAPOV, I. I., RYZHAVSKAYA, A. S., and SHAMSHIEV, A. T., Biotekhnologiya, 1995, (11), 15–18.
  • Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. ELCIN, Y. M., DIXIT, V., and GITNICK, G., Artif. Cells, Blood Substitutes, Immobilization Biotechnol, 1996, 24 (3), 257–271.
  • Cosmetic applications of liposomes. REDZINIAK, G., and PERRIER, P., Drugs Pharm. Sci., 1996, 73 (Microencapsulation), 577–585.
  • Crystallization phenomena of long-chain molecules in microspherically dispersed poly-mer. SATO, Y., UENO, S., SATO, K., and TSUTSUI, K., Nippon Kessho Seicho Gakkaishi, 1996, 23(3), 213.
  • Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. OYEN, W. J., BOERMAN, 0. C., STORNI, G., VAN BLOOIS, L., KOENDERS, E. B., CLAESSENS, R. A., PERENBOOM, R. M., CROMMELIN, D. J., VAN DER MEER, J. W., and CORSTENS, F. H., I. Nucl. Med., 1996, 37 (8), 1392–1397.
  • Determination of internal pH in PLGA microspheres using 31P NMR spectroscopy. BURKE, P. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23, 133–134.
  • Dielectric analysis of phosphorylcholine head group mobility in egg lecithin liposomes. SMITH, G., SHEKUNOV, B. Y., SHEN, H., DUFFY, A. P., ANWAR, J., WAKERLY, M. G., and CHAKRABARTI, R., Pharm. Res., 1996, 13(8), 1181–1185.
  • Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin. WASAN, K. M., and MORTON, R. E., Pharm. Res., 1996, 13 (3), 462–468.
  • Direct extraction of taste receptor proteins by liposome from intact epithelium of bullfrog tongue. NAKANIURA, M., TSUJI, K., and SUNAMOTO, J., Adv. Biomater. Biomed. Eng. Drug Delivery Syst., (Iketani Conf. Biomed. Polym), 1996, 5th, 271–272.
  • Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. SAKAKIBARA, T., CHEN, F. A., KIDA, H., KUNIEDA, K., CUENCA, R. E., MARTIN, F. J., and BANKERT, R. B., Cancer Res., 1996, 56 (16), 3743–3746.
  • Drug delivery to the brain using thermosensitive liposome and local hyperthermia. KAKINUMA, K., TANAKA, R., TAKAHASHI, H., SEKIHARA, Y., WATANABE, M., and KUROKI, M., int. J. Hyperthermia, 1996, 12 (1), 157–165.
  • Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis. CASTAGNOLA, E., DAVIDSON, R. N., FIORE, P., TASSO, L., Rossi, G., MANGRAVITI, S., Di MARTINO, L., Scorn, S., CASCIO, A., et al. Trans. R. Soc. Trop. Med. Hyg., 1996, 90 (3), 317–318.
  • Effect of formulation and processing factors on the characteristics of biodegradable micro-capsules of zidovudine. MANDAL, T. K., SHEKLETON, M., ONYEBUEKE, E., WASHINGTON, L., and PENSON, T., J. Microencapsulation, 1996, 13, (5), 545–557.
  • Effect of i.v. injection of small unilamellar liposomes of egg phosphatidylcholine on cholesterol in plasma and erythrocytes, serum enzymes and liver function in dogs. ZOMBER, G., BOGIN, E., and BARENHOLZ, Y., J. Liposome Res., 1996, 6 (2), 455–477.
  • Effect of superdisintegrant on antigen release from enteric-coated antigen microspheres. ZHANG, J. A., and CHRISTENSEN, J. M., Drug Dev. Ind. Pharm., 1996, 22 (8), 833–839.
  • Effect of vehicle on topical liposomal drug delivery: petrolatum bases. FOLDVARI, M., y. Microencapsulation, 1996, 13 (5), 589–600.
  • Effect of a chemically stable isocarbacyclin methylester incorporated in lipid microspheres (TTC-909) on thrombus formation and disaggregation in the microvasculature of the hamster cheek pouch. GOTO, J., ARAKI, H., HIGuctil, S., Sim, A. K., and TANABE, H., Oyo Yakuri, 1996, 51(6), 301–305.
  • Effect of liposomal composition on photoactivated liposome fusion. MILLER, C. R., BENNETT, D. E., CHANG, D. Y., and O'BRIEN, D. F., Biochemistry, 1996, 35 (36), 11782–11790.
  • Effect of molecular weight and storage times on tolmetin release from poly(DL-lactide) microspheres to lipid model membrane. A calorimetric study. CAsTELLI, F., CONTI, B., CONTE, U., and Puousi, G., J. Controlled Release, 1996, 40 (3), 277–284.
  • Effects of COR6.6 and COR15am polypeptides encoded by COR (cold-regulated) genes of Arabidopsis thaliana on the freeze-induced fusion and leakage of liposomes. UEMURA, M., GILMOUR, S. J., THOMASHOW, M. F., and STEPONKUS, P. L., Plant-Physiol, 1996, 111 (1), 313–327.
  • Effects of phosphatidylserine, and cholesterol liposomes on the viability, motility,, and acrosomal integrity of stallion spermatozoa prior to, and after cryopreservation. WILHELM, K. M., GRAHAM, J. K., and SQUIRES, E. L., Cryobiology, 1996, 33 (3), 320–329.
  • Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. Suzum, H., NODA, Y., GAO, X. P., SEJOURNE, F., ALKAN, 0. H., PAUL, S., and RUBINSTEIN, 1., Am. y. Physiol., 1996, 271 (1, Pt. 2), H282–H287.
  • Enhanced efficacy of a liposomal pentamidine preparation in Pneumocystis carinii in an ex vivolin vitro culture model without feederlayer cells. SAHM, M., WINGEN, F., HAGER, J., and SEITZ, H. M., Appl.-Parasitol., 1996, 37(2), 137–145.
  • Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted lipo-somes. ZALIPSKY, S., HANSEN, C. B., OAKS, J. M., and ALLEN, T.y. Pharm. Sc., 1996, 85(2), 133–137.
  • Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis. WASAN, K. M., and CONKLIN, 3. S., Antimicrob. Agents Chemother., 1996, 40 (8), 1806–1810.
  • Experimental study of internal radiation with yttrium-90 microspheres in the treatment of mouse transplanted hepatoma. LONG, L., DONG, B., and Li, J., Chung Hua Chung Liu Tsa Chih, 1995, 17 (6), 461–463.
  • Experimental intraperitoneal administration of liposomes containing adriamycin. KATO, F., Suzuxi, K., and SUZUKI, K., Tokyo Ika Daigaku Zasshi, 1996, 54 (3), 223–233.
  • Factors influencing release of salbutamol sulfate from poly(lactide-co-glycolide) micro-spheres prepared by water-in-oil-in-water emulsion technique. ERDEN, N., and CELEBI, N., Int. y. Pharm., 1996, 137 (1), 57–66.
  • Fate of cationic liposomes and their complex with oligonucleotide in vivo. LITZINGER, D. C., BRowN, J. M., WALA, I., KAUFMAN, S. A., VAN, G. V., FARRELL, C. L., and COLLINS, D., Biochim. Biophys. Acta, 1996, 1281 (2), 139–149.
  • Fluorescence polarization study on the dynamics and location of peroxidized fluorescent phospholipids in liposomes. WANG, 3. V., SUZUKI, K., MIYAZAWA, T., UEKI, T., and KOUYAMA, T., Arch. Biochem. Biophys., 1996, 330 (2), 387–394.
  • Functional particles by dispersion polymerization, 4: Core-shell tunable surface micro-spheres for selective enzyme adsorption. DINNELLA, C., LAUS, M., LANZARINI, G., and DORIA, M., Polym. Adv. Technol., 1996, 7 (5 & 6), 548–552.
  • Functions of monodisperse, thermosensitive hydrogel microspheres. KAWAGUCHI, H., Front. Biomed. Biotechnol., 1996, 3, 157–168.
  • Fundamental studies of targeting chemotherapy with cisplatin encapsulated liposome. KOKETSU, M., Nagoya-shiritsu Daigaku Igakkai Zasshi, 1996, 47 (2), 139–154.
  • Fusigenic liposome-mediated DNA transfer into cardiac myocytes. ELLISON, K. E., BISHOPRIC, N. H., WEBSTER, K. A., MORISHITA, R., GIBBONS, G. H., KANEDA, Y., SATO, B., and DZAU, V. J., J. Mol. Cell Cardiol., 1996, 28 (7), 1385–1399.
  • Fusion of reconstituted influenza virus envelopes with liposomes mediated by streptavidin / biotin interactions. SCHOEN, P., LESERMAN, L., and WILSCHUT, J., FEBS Lett., 1996, 390 (3), 315–318.
  • Glycoprotein mediated cell binding of lectin coated liposomes. SCHAEFER, H., STAVIN, R., SCHREIBER, J., and SCHMIDT, W., y. Liposome Res., 1996, 6(2), 479–496.
  • Graft copolymers having hydrophobic backbone and hydrophilic branches. XI. Preparation and thermosensitive properties of polystyrene microspheres having poly(N-isopro-pylacrylamide) branches on their surfaces. CHEN, M. Q., KISHIDA, A., and AKASHI, M., J. Polym. Sci., Part A: Polym. Chem., 1996, 34(11), 2213–2220.
  • High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. GREGORIAD1S, G., SAFFIE, R., and HART, S. L., J. Drug Targeting, 1996, 3 (6), 469–475.
  • Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macro-phages and THP-1 cells to cytotoxicity by cationic liposomes. KONOPKA, K., PRETZER, E., FELGNER, P. L., and DUZGUNECS, N., Biochim. Biophys. Acta, 1996, 1312 (3), 186–196.
  • Immobilization of E. coli L-asparaginase on chitosan microspheres. QIAN, G., ZHOU, J., MA, J., WANG, D., and HE, B., Gaodeng Xuexiao Huaxue Xuebao, 1996, 17 (7), 1147–1150.
  • Improved antitumor activity of cis-Bis-neodecanoato-trans-R, R-1,2-diaminocyclohexane-platinum (II) entrapped in long-circulating liposomes. 1A, S., KHOKHAR, A. R., PEREZ, S. R., and HUANG, L., Oncol. Res., 1995, 7 (12), 611–617.
  • Improvement of pharmacokinetics and antitumor activity against human hepatoma cell line by using adriamycin-entrapped stealth liposomes. SHIMIZU, H., Kumst, K., UyAmA, I., SHIBATA, S., TAGAWA, T., NAGAIKE, K., YASUDA, T., KITAJIMA, M., and TADAKUMA, T., 3. Surg. Oncol., 1996, 62 (3), 186–193.
  • In vitro and in vivo degradation of double-walled polymer microspheres. PEKAREK, K. J., DYRUD, M. J., FERRER, K., Jorsc, Y. S., and MATHIOWITZ, E.,3. Controlled Release, 1996, 40 (3), 169–178.
  • In situ polycondensation of amino acid modified liposomes and their properties. Lt, Z. C., HE, W., and Li, F. M., React. Funct. Polym., 1996, 30 (1–3), 299–3 vitro and in vivo evaluation of chitosan microspheres of anti-inflammatory drugs. VURAL, ACIKGOZ, M., KAS, H. S., ERCAN, M. T., HASCELIK, Z., and HINCAL, A. A., Chitin World, 1994, (Proc. Int. Conf. Chitin. Chitosara), 6th, 562–574.
  • In vitro penetration into bovine oocytes and zona-free hamster oocytes by bull spermatozoa treated with liposomes. TRUELSON, S. L., GRAHAM, J. K., MORTIMER, R. G., and FIELD, T. G., 3. Dairy Sci., 1996, 79 (6), 991–999.
  • In vitro release test system of (DL-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin). KAMIJO, A., KAMM, S., SAIKAWA, A., lomu, Y., and OGAWA, Y., 3. Controlled Release, 1996, 40 (3), 269–276.
  • In vivo studies of amylose- and ethyl cellulose-coated (13C) glucose microspheres as a model for drug delivery to the colon. CUMMINGS, J. H., MILOJEVIC, S., HARDING, M., COWARD, W. A., GIBSON, G. R., BOTHAM, R. L., RING, S. G., WRAIGHT, E. P., STOCKHAM, M. A., et al. .7. Controlled Release, 1996, 40 (1–2), 123–131.
  • In vivo trafficking of long-circulating liposomes in tumor-bearing mice determined by positron emission tomography. OKU, N., TOKUDOME, Y., TSUKADA, H., KOSUGI, T., NAMBA, Y., and OKADA, S., Biopharm. Drug Dispos., 1996, 17 (5), 435–441.
  • In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. EGILMEZ, N. K., CUENCA, R., YOKOTA, S. J., SORGI, F., and BANKERT, R. B., Gene Ther., 1996, 3 (7), 607–614.
  • In vitro studies of liposome-mediated gene transfection. YANG, K., PEREZ, P. J., FAUSTINELLA, F., TAGLIALATELA, G., and HAYES, R. L., Methods Neurosci., 1996, 30 (Paradigms of Neural Injury), 290–297.
  • In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate. FARSHI, F. S., OZER, A. Y., ERCAN, M. T., and HINCAL, A. A., 3. Microencapsulation, 1996, 13 (5), 537–544.
  • Increased toxicity and specificity of cytosine arabinoside by liposomal encapsulation in itnmunoliposomes. GANSAUGE, S., GANSAUGE, F., MUELLER, C. A., SCHOTT, H., and BEGER, H. G., Chir. Forum. Exp. Kiln. Forsch. (Suppl. 1), 1996, pp. 523–526.
  • Increased liposome extravasation in selected tissues: effect of substance P. ROSENECKER, J., ZHANG, W., HONG, K., LAUSIER, J., GEPPETTI, P., YOSHIHARA, S., PAPAHADJOPOULOS, D., and NADEL, J. A., Proc. Natl. Acad. Sci. USA, 1996,93 (14), 7236–7241.
  • Indomethacin-loaded chitosan microspheres. Correlation between the erosion process, and release kinetics. ORIENTI, I., AIEDEH, K., GIANASI, E., BERTASI, V., and ZECCHI, V., J. Microencapsulation, 1996, 13 (4), 463–472.
  • Influence of physicochemical properties of fluoroquinolones on encapsulation efficiency in liposomes. MONTERO, M. T., SAIZ, D., SITGES, R., VAZQUEZ, J. L., and BOREELL, J. H., Int. Y. Pharm., 1996, 138(1), 113–120.
  • Influence of scale-up factors on particle size in microcapsule dispersion process. TAICAHASH I, K., Sumitomo Kagaku (Osaka), 1996, (1), 71–76.
  • Influenza-virus-liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane. SHANGGUAN, T., ALFORD, D., and BENTZ, J., Biochemistry, 1996, 35 (15), 4956–4965.
  • Inhibition of influenza virus RNA polymerase, and nucleoprotein gene expression by unmodi-fied, phosphorothioated,, and liposomally encapsulated oligonucleotides. HATTA, T., NAKAGAWA, Y., TAKAI, K., NAICADA, S., YOKOTA, T., and TAKAKU, H., Biochem. Biophys. Res. Commun., 1996, 223 (2), 341–346.
  • Interaction of 4-(p-dimethylaminostyry1)-1-methylpyridinium p-toluenesulfonate with lipo-somes. Fluorescence spectra analysis. GORBENKO, G. P., and DYUBKO, T. S., Biofizika, 1996, 41(2), 348–354.
  • Interaction of polyethylene oxide-bearing lipid reconstituted liposomes with murine B16 melanoma cells. HARATAKE, M., and SUNAMOTO, J., Adv. Biomater. Biomed. Eng. Drug. Delivery Syst., (Iketani Conf., Biomed., Polym.), 1996, pp. 335–336.
  • Interaction of RGD liposomes with platelets. NISHIYA, T., and SLOAN, S., Biochem. Biophys. Res. Commun., 1996, 224 (1), 242–245.
  • Interfacial/free radical polymerization microencapsulation: kinetics of particle formation. MAHABADI, AHABADI. K., NG, T. H., and TAN, H. s., 7. Microencapsulation, 1996, 13 (5), 559-573. Interferon-gamma inductive effect of liposomes as an immunoadjuvant. ARAMAKI, Y., SuDA, H., and TSUCHIYA, S., Vaccine, 1995, 13 (18), 1809–1814.
  • Intermediate aggregates resulting in the interaction of sodium dodecyl sulfate with phos-phatidylcholine liposomes. MAZA, A., and PARRA, J. L., Colloids Surf., A, 1996, 112(1), 63–71.
  • Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. KITAMURA, I., KOCHI, M., MATSUMOTO, Y., UsoKA, R., KURATSU, J., and USHIO, Y., Cancer Res., 1996, 56(17), 3986–3992.
  • Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. HUSAIN, D., MILLER, J. W., MICHAUD, N., CONNOLLY, E., FLorrs, T. J., and GRAGOUDAS, E. S., Arch. Ophthalmol., 1996, 114,(8), 978–985.
  • IR spectroscopic study of carbonization of phenol-formaldehyde composites filled with microspheres. EREMEEVA, M. A., MOKHOVIKOVA, T. A., BELEVERYA, T. D., SIMONOV, E. I. D., and KORSAKOV, V. G., Vysokomol Soedin, Ser A Ser B, 1995, 37(8), 1435–1437.
  • Lipid composition influence on the surfactant-induced release of the contents in liposomes formed by lipids modeling the stratum corneum. DE LA MAZA, A., MANICH, A. M., CODERCH, L., BAUCELLS, J., and PARRA, J. L., Colloids Surf., A, 1996, 113 (3), 259–267.
  • Lipid vehicles for the parenteral administration of drugs (2): liposomes. BERMEJO, V. T., CARRASCO, R. J. M., and HIDALGO, C. F. J., Nutr-Hosp, 1996, 11(2), 69–81.
  • Liposomal methylprednisolone in rats: dose-proportionality and chronic-dose pharmaco-kinetics/pharmacodynamics. MISHINA, E. V., and JusKo, W. J., Pharm. Res., 1996, 13 (1), 141–145.
  • Liposomal targeting and drug delivery: kinetic consideration. HARASHIMA, H., and KIWADA, H., Adv. Drug Delivery Rev., 1996, 19 (3), 425–444.
  • Liposome delivered and polymeric metal complexes as potential sensitizers for the photo-dynamic therapy of cancer. WOEHRLE, D., SHOPOVA, M., MOSER, J. G., KLIESCH, H., MICHELSEN, U., MUELLER, S., and WEITEMEYER, A., Macromol. Symp., 1996, 105, 127–138.
  • Liposome mediated IL-2 gene therapy and its in vivo biological effects. WANG, Q., CAo, X., ZHANG, W., WANG-JIANLI, XU, Z., and YE, T., Mianyixue Zazhi, 1996, 12 (1), 20–24.
  • Liposome behavior in capillary electrophoresis. ROBERTS, M. A., LOCASCIO, B. L., MACCREHAN, W. A., and DURST, R. A., Anal. Chem., 1996, 68 (19), 3434–3440.
  • Liposome-based cancer vaccines. BERGERS, J. J., OTTER, W. D., and CROMMELIN, D. J. A., 7. Liposome Res., 1996, 6 (2), 339–355.
  • Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet? ZELPHATI, 0., and SZOKA, F. C. JR., 7. Controlled Release, 1996, 41, 99–119.
  • Liposomes and biopolymers in drug and gene delivery. LASIC, D. D., and PAPAHADJOPOULOS, D., Curr. Opin. Solid State Mater. Sci., 1996, 1 (3), 392–400.
  • Liposomes as immunological adjuvants and vaccine carriers. GREGORIADIS, G., GURSEL, I., GURSEL, M., and McCoamAcx, B., y. Controlled Release, 1996, 41, 49–56.
  • Liposomes in gene therapy. LASIC, D. D., Chim. Oggi, 1996, 14 (3/4), 13–16.
  • Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphos-phatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). KIRPOTIN, D., HONG, K., MULLAH, N., PAPAHADJOPOULOS, D., and ZALIPSKY, S., FEBS Lett., 1996, 388 (2-3), 115–118.
  • Liposomes: small lipid shuttles with precious contents. RIMOLDI, E., Tecnol. Chim., 1996, 16 (4), 48–51.
  • Long circulating liposomes: past present and future. MARJAN, J. M. J., and ALLEN, T. M., Biotechnol. Adv., 1996, 14 (2), 151–175.
  • Melt crystallization of behenic acid in microspheres dispersed in polymer. TSUTSUI, K., HorrA, Y., and SATO, K., .7. Cryst. Growth, 1996, 163 (4), 440–444.
  • Microcapsular quinalphos formulation: in vitro and in vivo evaluations. BHASKAR, C., and SHUKLA, HUKLA. G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 371-372.Microcapsule-immobilized catalase. WANG, Y. J., Liu, C. B., BAI, G. Y., CHU, Y., WANG, F. P., MA, A. F., and ZHANG, H. Z., Gaodeng Xuexiao Huaxue Xuebao, 1996, 17 (6), 953-956.Microcapsules: preparation by interfacial polymerization and interfacial complexation and their applications. WHATELEY, T. L., Drugs Pharm. Sci., 1996, 73, 349–375.
  • Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. PRAKASH, S., and CHANG, T. M. S., Nat. Med., (N Y), 1996, 2 (8), 883–887.
  • Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats. PRAKASH, S., and CHANG, T. M. S., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1996, 24 (3), 201–218.
  • Microencapsulation of allopurinol by solvent evaporation and controlled release investiga-tion of drugs. ARABI, H., HASHEMI, S. A., and FOOLADI, M., Y. Microencapsulation, 1996, 13 (5), 527–535.
  • Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy. BASIC, D., VACEK, I., and SUN, A. M., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1996, 24 (3), 219–255.
  • Microencapsulation of an iron chelator for sustained release and crystal habit modification. VENKATARAm, S., and KHOHLOKWANE, M., y. Microencapsulation, 1996, 13 (5), 519–525.
  • Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method. UCHIDA, T., YAGI, A., ODA, Y., and GOTO, S.,.7. Microencapsulation, 1996, 13 (5), 509–518.
  • Microencapsulation of Naproxen using rapid expansion of supercritical solutions. Kim, J. H., PAXTON, T. E., and TOMASKO, D. L., Biotechnol. Prog., 1996, 12 (5), 650–661.
  • Microencapsulation of oil-in-water emulsions by proteins. MAGDASSI, S., and VINETSKY, Y., Drugs Pharm. Sci., 1996, 73, 21–33.
  • Microencapsulation of vaccines. JONES, D. H., Vaccine Protoc., Humana, Totowa, N. y., 1996, pp. 157–166.
  • Micromeritic studies on nicardipine hydrochloride microcapsules. OEZYAZICI, M., SEVGI, F., and ERTAN, G., Int. y. Pharm., 1996, 138 (1), 25–35.
  • Microsphere morphology. BENOIT, J. P., and THIES, C., Drugs Pharm. Sci., 1996, 73, 133–154.
  • Microspheres based detoxification system: a new method in convective blood purification. APPEN, K., WEBER, C., LOSERT, U., SCHIMA, H., GURLAND, H. J., and FALKENHAGEN, D., Artif. Organs, 1996, 20 (5), 420–425.
  • Microspheres which are carriers of lipid-soluble active principles. HERNANDEZ, P. J., and CEREZO, A., Cienc. Pharm., 1996, 6 (3), 143–149.
  • Modification of liposomes for liver targeting. Wu, J., and ZERN, M. A.,.7. Hepatol., 1996, 24 (6), 757–763.
  • Modulation of protein release from chitosan-alginate microcapsules using the p11-sensitive polymer hydroxypropyl methyl cellulose acetate succinate. OKHAMAFE, A. 0., AMSDEN, B., CHU, W., and GOOSEN, M. F. A.,Microencapsulation, 1996, 13 (5), 497–508.
  • Monitoring by cis-parinaric fluorescence of free radical induced lipid peroxidation in aqueous liposome suspensions. DI GIULIO, A., SALETTI, M. A., ORATORE, A., and BOZZI, A., .7. Microencapsulation, 1996, 13 (4), 435–445.
  • Monosized, silica-based microspheres for chromatographic separations. JELINEK, L., OHNIACHT, R., and PFENNINGER, A., Am. Biotechnol. Lab., 1996, 14 (6), 18, 20.
  • New method to form giant liposome entrapping DNA. KUMAZAWA, N., Hyomen Kagaku, 1996, 17 (6), 328–334.
  • Nifedipine and nifedipine-cyclodextrin complexes in liposomes and microspheres. SKALKO, N., FILIPOVIC, G. J., BECIREVIC, L. M., and JALSENJAK, I., Acta Pharm. (Zagreb). 1996, 46 (2), 159–168.
  • Non-phospholipid liposomes: a novel method for the preparation of hemoglobin containing lipid vesicles. ROHLFS, R. J., and VANDEGR/FF, K. D., Blood Substitutes: New Challenges, 1996, pp. 163–184.
  • Novel homogeneous liposomal immunoassay for colorimetric estimation of serum IgG anticardiolipin antibodies. FROST, S. J., CHAKRABORTY, J., and FIRTH, G. B., Clin. Chem., 1996, 42 (6 Pt 1), 874–879.
  • On the ultimate Q of optical microsphere resonators. GORODETSKY, M. L., SAVCHENKOV, A. A., and ILCHENKO, V. S., Proc. SPIE-Int. Soc. Opt. Eng., 1996, 2799 (Atomic and Quantum Optics: High-Precision Measurements), 389–391.
  • Opioid receptor affinity of multivalent ligand system consisting of polymerized liposome. TETSUI, ETSUI., ZHAO, J., Kimum, S., and IMANISHI, Y Int.J. Pept. Protein Res., 1996, 48(1), 95-101. Optimal radiolabeled liposomes for tumor imaging. OGIHARA, U. I., SASAKI, T., KOJIMA, S., and NISHIGORI, ISHIGORI., J. Nucl. Med., 1996, 37 (2), 326–332.
  • Optimizing dosage regimens of liposomal amphotericin B using Aspergillus murine model. KOTWANI, R. N., GOKHALE, P. C., KSHIRSAGAR, N. A., and PANDYA, S. K., Indian y. Pharmacol, 1996, 28 (2), 88–92.
  • Oral immunization with a model protein entrapped in microspheres prepared from deri-vatized alpha-amino acids. HAAS, S., MIURA, F. J., ZAVALA, F., MURATA, K., LEONE, B. A., and SANTIAGO, N., Vaccine, 14(8), 785–791.
  • pH-Sensitive liposomes and antisense oligonucleotide delivery. MILHAUD, P. G., BONGARTZ, J. P., LEBLEU, B., PHILIPPOT, J. R., Drug Delivery, 1996, 3 (2), 67–73.
  • Pharmaceutical evaluation of gelatin microspheres crosslinked with dl-glyceraldehyde. Determinations of residuals of the preparation procedure. GRIFFIN], A., VANDELLI, M. A., SEGHIZZI, R., Mucci, A., and PIFFERI, G., Pharm. Pharmacol. Lett., 1996, 6 (1), 16–18.
  • Pharmaceutical aspects of liposomes: perspectives in, and integration of, academic and industrial research and development. MARGALIT, R., and YERUSHALMI, N., Drugs Pharm. Sci., 1996, 73 (Microencapsulation), 259–295.
  • Pharmacokinetic characteristics of two types of liposomal FK 506. YAGURA, K., NAKAJIMA, Y., Ko, S., KANEHIRO, H., and NAKANO, H., Transplant Proc., 1996, 28 (3), 1390–1391.
  • Pharmacokinetics of liposomal encapsulated carboplatin. Comparison of different loco-regional administrations. An animal study on the VX-2 liver tumor. BERGER, G., POHLEN, U., RESZKA, R., LIPPMANN, M., PAEUSER, S., and BUHR, H. J., Chir. FOTUM Exp. Klin. Forsch. (Suppl. 1), 1996, pp. 533–536.
  • Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. GIRARD, P.M., BOUCHAUD, 0., GOETSCHEL, A., MUKWAYA, G., EESTERMANS, G., Ross, M., ROZENBAUM, W., and SAIMOT, A. G., AIDS (London), 1996, 10 (7), 753–757.
  • Phenytoin sodium microcapsules: bench scale formulation, process characterization and release kinetics. Yazici, E., ONER, L., Kas, H. S., and HINCAL, A. A., Pharm. Dev. Technol., 1996, 1 (2), 175–183.
  • Phospholipids-liposomes-nanoemulsions. I. Production, legislation, and properties. GAREI, J., and RADOS, S. B., Cosmet. Toiletries, Ed hal, 1996, 17 (2), 80–81. 83–86.
  • Photodynamic therapy of human bladder carcinoma cells in vitro with liposomes as carrier for porphycene: 9-Acetamido-2,7,12,17-tetra-n-propylporphycene (AamTPPn). REICH, E., BACHOR, R., ZEIZEL, T., KLEINSCHMIDT, K., and HAUTMANN, R., Proc. SPIE-Int. Soc. Opt. Eng., 1996, 2625, 304–310.
  • Photoinduced drug release from liposome using photochromic lipid having spiropyran group. OHYA, Y OKUYAMA, Y., and OUCHI, T., Adv. Biomater. Biomed. Eng. Drug Delivery Syst., (Iketani Conf. Biomed. Polym.) 1996, pp. 353–354.
  • Poly(ethylene glycol) amphiphile adsorption and liposome partition. VAN ALSTINE, J. M., MALMSTEN, M., and BROOKS, D. E., J. Chromatogr., 1996, 680 (1 + 2), 1+5–155.
  • Polylysine enhances cationic liposome-mediated transfection of the hepatoblastoma cell line Hep G2. MACK, K. D., WALZEM, R. L., LEHMANN, B. K., POWELL, J. S., and ZELDIS, J. B., Biotechnol. Appl. Biochem., 1996, 23 (Pt 3), 217–220.
  • Polymer precipitation using a micellar nonsolvent: the role of surfactant-polymer inter-actions and the development of a microencapsulation technique. BANERJEE, S., PREM CHANDRAN, R., TATA, M., JOHN, V. T., MCPHERSON, G. L., AKKARA, J., and KAPLAN, D., Ind. Eng. Chem. Res., 1996, 35 (9), 3100–3107.
  • Polysaccharide microcapsules for the treatment of periodontitis. LEE, S. J., PARK, Y. J., LEE, M. J., YEOM, H. L., and CHUNG, C. P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 373–374.
  • Pore formation by S. aureus alpha-toxin in liposomes and planar lipid bilayers: effects of nonelectrolytes. BASHFORD, C. L., ALDER, G. M., FULFORD, L. G., KORCHEV, Y. E., KOVACS, E., MACKINNON, A., PEDERZOLLI, C., and PASTERNAK, C. A., _7. Membr. Biol.,1996, 150(1), 37–45.
  • Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl-alpha-cyclodextrin. UTSUKI, T., BREM, H., PITHA, J., LOFTSSON, T., KRISTMUNDSDOTTIR, T., TYLER, B. M., and Ouvi, A., J. Controlled Release, 1996, 40 (3), 251–260.
  • Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology. Aim, I. K. A., GARCIA, C. L., and Lu, D. R., J. Pharm. Sc., 1996, 85 (2), 144–149.
  • Preparation of biodegradable microcapsules of zidovudine using solvent evaporation: effect of the modification of aqueous phase. MANDAL, T. K., and TENJARLA, S., Int. Y. Pharm., 1996, 137 (2), 187–197.
  • Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens. KOFLER, N., RUEDL, C., KLImA, J., RECHEIS, H., BOCK, G., WICK, G., and WOLF, H., J. Immunol. Methods, 1996, 192 (1-2), 25–35.
  • Preparation and performance of slow release microcapsules containing nutrient by complex emulsion method. YOKOTA, Y., ISHIBASHI, K., YAMADA, K., TANAKA, S., PONDEVIDA, J. L., DOMINGUEZ, L. G., LALusis, B. M., PIGAO, C. G., and PANLASIGUI, R. A., Hokkaido Kogyo Gijutsu Kenkyusho Hokoku, 1996, 67, 6–10.
  • Preparation of 1251-F(a1:02-DNR-liposomes and radioimmunoassay of their specific con-jugating ability. Liu, J., CHEN, Z., Liu, H., FAN, Q., and SFIEN, D., Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, 1995, 17 (5), 383–386.
  • Preparation of biodegradable microspheres containing water-soluble drug, beta-lactam antibiotic. Kim, J. HEE., KWON, I. C., Kim, Y. H., SOHN, Y. T., and JEONG, S. Y., Adv. Biomater. Biomed. Eng. Drug Delivery Syst., (Iketani Conf. Biomed. Poiym.), 1996, pp. 365–366.
  • Preparation of double-layer microcapsules coated by a synthesized liquid and their controlled release. GOTO, M., NAKASHIO, F., IwAmA, M., YOHIZAWA, H., IJICHI, K., UEMURA, Y., and HATATE, Y Kagaku Kogaku Ronbunshu, 1996, 22 (4), 923–926.
  • Preparation of liposomes that mimic the membrane of endoplasmic reticulum of rat hepatocytes. WATANABE, J., ASAKA, Y., MINO, K., and KANAMURA, S., J. Electron. Microsc., (Tokyo), 1996, 45 (2), 171–176.
  • Preparation of polyurea microcapsules containing red blood cell (RBCs). KONDO, T., HAFEZ, E., MURAMATSU, N., EL HARRAS, S., and EL GIBALY, I., Saudi Pharm. y., 1996, 4 (2), 69–78. Preparation and characterization of liposomal adriamycin. FENG, B., LANG, J., and Li, D., Chung Hua I Hsueh Tsa Chih, 1995, 75 (10), 614–616. 640.
  • Preparation and characterization of poly(DL-lactic acid) microspheres containing alpra-zolam. YONG, C. S., KWON, M. R., PARK, S. H., and OH, D. M., Yakche Hakhoechi, 1996, 26 (1), 13–22.
  • Preparation of oral berberine bisulfate liposomes. Xue, Y., WENG, G., HE, J., and Xu, B., Chung Kuo Chung Yao Tsa Chili, 1995, 20 (12), 730–731. 762–763.
  • Preparation, structure and release profile of polypeptide microcapsules. KIDCHOB, T., KIMURA, S., and IMANISHI, Y., 9. Controlled Release, 1996, 40 (3), 285–291.
  • Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes. SUNTRES, Z. E., and SHER, P. N., .7. Drug Target., 1995, 3(3), 201–208.
  • Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester micro-spheres. CURLEY, J., CASTILLO, J., HOTZ, J., UEZONO, M., HERNANDEZ, S., LIM, J. 0., TIGNER, J., CHASIN, M., LANGER, R., and BERDE, C., Anesthesiology, 1996, 84 (6), 1401–1410.
  • Properties of practical oral liposome-Streptococcus mutans glucosyltransferase vaccines for effective induction of caries protection. CHILDERS, N. K., ZHANG, S. S., HAROKOPAKIS, E., HARMON, C. C., and MICHALEK, S. M., Oral Microbiol. Immunol., 1996, 11 (3), 172–180.
  • Protamine-induced aggregation of unilamellar liposomes. KULKARNI, S. B., DIPALI, S. R., and BETAGERI, G. V., Pharm. Sci., 1995, 1(8), 359–362.
  • Quantitative evaluation of human leukocyte interferon-a entrapped in liposomes. KARAU, C., PONGPAIBUL, Y., and SCHMIDT, P. C., Drug Delivery, 1996, 3 (2), 59–65.
  • Quantitative determination of hydrophobic compound entrapment in dipalmitoylphos-phatidylcholine liposomes by differential scanning calorimetry. MONTENEGRO, L., PANIC°, A. M., and BONINA, F., Int. y. Pharm., 1996, 138 (2), 191–197.
  • Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. GILL, P. S., WERNZ, J., SCADDEN, D. T., COHEN, P., MUKWAYA, G. M., VON ROENN, J. H., JAcoBs, M., KEMPIN, S., SILVEREIERG, I., GONZALES, G., RARICK, M. U., MYERS, A. M., SHEPHERD, F., SAWKA, C., PIKE, M. C., and Ross, M. E., 9. Clin. Oncol., 1996, 14 (8), 2353–2364.
  • Rapid method for visual identification of specific DNA sequences based on DNA-tagged liposomes. RULE, G. S., MONTAGNA, R. A., and DURST, R. A., Clin. Chem., 1996, 42 (8 Pt 1), 1206–1209.
  • Receptor affinity of neurotensin message segment immobilized on liposome. ZHAO, J., KIMURA, S., and ImArmsw, Y Biochim. Biophys. Acta, 1996, 1282 (2), 249–256.
  • Reconstitution of the steroidogenic pathway from cholesterol to aldosterone in liposome membranes. KOMINAMI, S., NISHIDA, N., and TAKEMORI, S., Biochim. Biophys. Acta, 1996, 1301 (3), 199–206.
  • Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits. LE BOURLAIS, C., CHEVANNE, F., ROPERT, P., BRETAGNE, G., ACAR, L., ZIA, H., SADO, P. A., NEEDHAM, T., and LEVERGE, R., y. Microencapsulation, 1996, 13 (4), 473–480.
  • Reversed-phase liquid chromatography on a microspherical carbon column at high temper-ature. YAMAKI, S., Ison, T., OKUYAMA, T., and SHINODA, T., y. Chromatogr. A., 1996, 728 (1-2), 189–194.
  • Rifampicin carrying poly(DL-lactide)/poly(ethylene glycol) microspheres: loading and re-lease. CELIKKAYA, E., DENKBAS, E. B., and PISKIN, E., Artif. Organs, 1996, 20 (7), 743–751.
  • Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. HEPPNER, D. G., GORDON, D. M., GROSS, M., WELLDE, B., LEITNER, W., KRZYCH, U., SCHNEIDER, I., WIRTZ, R. A., RICHARDS, R. L., TROFA, A., HALL, T., SADOFF, J. C., BOERGER, P., ALVING, C. R., SYLVESTER, D. R., PORTER, T. G., and BALLOU, W. R., y. Infect. Dis., 1996, 174 (2), 361–366.
  • Scattering studies of poly(urea-urethane) microcapsules in suspension. DOBASHI, T., TAKENAKA, M., YEH, F. J., Wu, G., ICHIKAWA, K., and CHU, B., J. Colloid Interface Sci., 1996, 179 (2), 640–642.
  • Selective drug delivery through and within skin using liposomes. SINGH, R., and VYAS, S. P., Indian). Pharm. Sci., 1996, 58 (1), 9–17.
  • Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). DAVIDSON, AVIDSON. N., DI MARTINO, L., GRADONI, L., GIACCHINO, R., GAETA, G. B., PEMPINELLO, R., SCOTT, S., CASCIO, A., CASTAGNOLA, E., et al., Clin. Infect. Dis., 1996, 22(6), 938–943.
  • Silica microspheres for photon trapping. LEFEVRE, V., Bull. Soc. Fr. Phys., 1996, 105, 24–28.
  • Simultaneous determination of' twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-pm porous microspherical silica gel. TANAKA, ANAKA., TERADA, M., MISAWA, S., and WAKASUGI, C., J. Chromatogr., B: Biomed. App/., 1996, 682 (1), 173–178.
  • Sodium ion translocation by N5-methyltetrahydromethanopterin: coenzyme M methyltrans-ferase from Methanosarcina mazei God l reconstituted in ether lipid liposomes. LIENARD, T., BECHER, B., MARSCHALL, M., BOWIEN, S., and GOTTSHALK, G., Eur. J. Biochem., 1996, 239 (3), 857–864.
  • Solubilizing effects caused by the nonionic surfactant octyl glucoside in phosphatidylcholine liposomes. DE LA MAZA, A., and PARRA, J. L., J. Am. Oil Chem. Soc., 1996, 73 (7), 877–883.
  • Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism. HARASHIMA, H., KOMATSU, S., KOJIMA, S., YANAGI, C., MORIOKA, Y., NAITO, M., and KIWADA, H., Pharm. Res., 1996, 13 (7), 1048–1054.
  • Spectral properties and the binding ability of hypocrellin A in liposomes. Zou, W., AN, J. Y., and JIANG, L. J., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1995, 27 (6), 685–689.
  • Stability assay and preparation of liposome entrapped indomethacin injection. DENG, Y Li, H., ZHANG, R., and Yu, B., Shenyang Yaoke Daxue Xuebao, 1996, 13 (2); 79–81. 97.
  • Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. CHANG, A. C., and GUPTA, R. K.,). Pharm. Sci., 1996, 85(2), 129–132.
  • Stealth liposomes. LASIC, D. D., Drugs Pharm. Sci., 1996, 73 (Microencapsulation), 297–328. Stoichiometry of hypochlorite interaction with unsaturated bonds of phosphatidylcholine and free fatty acids in liposomes. PANASENKO, 0. M., ARNHOLD, J., SERGIENKO, V. I., ARNOLD, K., and VLADIMIROV, Y. A., Biol. Membr., 1996, 13 (3), 271–281.
  • Structural and functional characterization of liposomal recombinant hepatitis B vaccine. DIMINSKY, D., REIMANN, Z. J., SCHIRMBECK, R., and BARENHOLZ, Y., y. Liposome Res., 1996, 6 (2), 289–304.
  • Structuring of non-magnetic microspheres in a planar layer of a ferrocolloid in rotating magnetic field. KHIZHENKOV, P. K., MAKMAK, I. M., and GOROBETS, S. V., Magn. Gidrodin., 1995, 31(1-2), 113–115.
  • Studies on hepatic arterial embolization with cisplatin-chitosan-microspheres in dogs. WANG, Y. M., SHI, T. S., Pu, Y. L., ZHU, J. G., and ZHAO, Y. L., Yao Hsueh Hsueh Pao, 1995, 30 (12), 891–895.
  • Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. BLANCO, P. M. J., LEO, E., DELIE, F., GuLIK, A., COUVREUR, P., and FArrAL, E., Pharm. Res., 1996, 13 (7), 1127–1129.
  • Study on emulsion non-solvent addition method of compound polymer microcapsules. DONG, Q., Guo, Q., and TANG, W., Gaofenzi, Cailiao Kexue Yu Gongcheng, 1996, 12 (3), 137–140.
  • Surface modification of continuously extruded contrast-carrying liposomes: effect on their physical properties. SCHNEIDER, T., SACHSE, A., LEIKE, J., ROESSLING, G., SCHMIDTGEN, M., DRECHSLER, M., and BRANDL, M., Int.). Pharm., 1996, 132 (1, 2), 9–21.
  • Synthesis and study of microspherical gamma-aminopropylpolysiloxanes for chromato-graphy of natural compounds. EMEL, I. S., and CHERNYKH, G. P., Zh. Obshch Khim, 1995, 65 (10), 1690–1692.
  • Synthesis and evaluation of neoglycolipid for liposome modification. MURAHASHI, N., YAMADA, H., WATANABE, H. K., HIGASHI, K., MIYOSHI, S., YAMAUCHI, H., and NAKABAYASHI, S., Drug Delivery Syst., 1996, 11(2), 91–97.
  • Synthetic glycolipids as membrane-bound cryoprotectants in the freeze-drying process of liposomes. BENDAS, G., WILHELM, F., RICHTER, W., and NUHN, P., Fur. Pharm. Sci., 1996, 4(4), 211–222.
  • Synthetic cationic amphiphile for liposome-mediated DNA transfection with less cytotoxicity. KATO, T., IWAMOTO, K., ANDO, H., ASAKAWA, N., TANAKA, I., KIKUCHI, J., and MURAKAMI, Y., Biol. Pharm. Bull., 1996, 19 (6), 860–863.
  • Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-gly-colide) microspheres: importance of polymer degradation and antigen release for immune response. THOMASIN, C., CORRADIN, G., MEN, Y., MERKLE, H. P., and GANDER, B., 9. Controlled Release, 1996, 41, 131–145.
  • The role of helper lipids in cationic liposome-mediated gene transfer. Hui, S. W., LANGNER, M., ZHAO, Y. L., Ross, P., HURLEY, E., and CHAN, K., Biophys. y., 1996, 71(2), 590–599.
  • The effect of microfluidization of protein-coated liposomes on protein distribution on the surface of generated small vesicles. SKALKO, N., BOUWSTRA, J., SPIES, F., and GREGORIADIS, G., Biochim. Biophys. Acta, 1996, 1301 (3), 249–254.
  • The effect of the stability of the multiple emulsion on the preparation of polylactide microspheres containing a hydrophilic drug. Km, J. H., KWON, I. C., KIM, Y. H., SOHN, Y. T., and JEcavo, S. Y., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 341–342.
  • The influence of Pseudomonas aeruginosa on liposomes. ANTOS, M., TRAFNY, E. A., and GRZYBOWSKI, J., Folio Microbiol. (Prague), 1996, 41(1), 29–32.
  • The rheological properties of glass microsphere filled polypropylene. LIAO, J., ZHENG, H., and Hu, S., Hecheng Shuzhi Yi Suliao, 1996, 13 (1), 35–38.
  • The use of adjuvants in experimental vaccines. III. Liposomes. STEWART, T. D. E. S., Vaccine Protoc, (Humana, Totowa, N. J.,), 1996.
  • Topology of multivesicular liposomes, a model biliquid foam. SPECTOR, M. S., ZASADZINSKI, J. A., and SANKARAM, M. B., Langmuir, 1996, 12 (20), 4704–4708.
  • Transfer of membrane proteins from human erythrocytes to liposomes. OKUMURA, Y., Suzuxi, K., GOTO, M., and SUNAMOTO, J., Adv. Biomater. Biomed. Eng. Drug Delivery Syst., 1996, pp. 275–276.
  • Tumor targeting in vivo by means of thermolabile fusogenic liposomes. ZELLMER, S., and CEVC, G.,9. Drug Targeting, 1996, 4 (1), 19–29.
  • Ultimate Q of optical microsphere resonators. GORODETSKY, M. L., SAVCHENKOV, A. A., and ILCHENKO, V. S., Opt. Lett., 1996, 21(7), 453–455.
  • Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver ma-lignancies. TIAN, J. H., Xu, B. X., ZHANG, J. M., DONG, B. W., LIANG, P., and WANG, X. D., 9. Nucl. Med., 1996, 37 (6), 958–963.
  • Unidirectional reconstitution into detergent-destabilized liposomes of the purified lactose transport system of Streptococcus thermophilus. KNOL, J., VEENHOFF, L., LIANG, W. J., HENDERSON, P. J. F., LEBLANC, G., and POOLMAN, B., y. Biol. Chem., 1996, 271 (26), 15358–15366.
  • Use of liposome-associated bupivacaine in a cancer pain syndrome. LAFONT, N. D., LEGROS, F. J., and BOOGAERTS, J. G., Anaesthesia, 1996, 51(6), 578–579.
  • Utilization of surface-coated liposomes for oral dosage forms. IWANAGA, K., ONO, S., MORIMOTO, K., KAKEMI, M., YAMASHITA, S., and Oxu, N., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 527–528.
  • Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal am-photericin B (AmBisome). Russo, R., NIGRO, L. C., MINNITI, S., MONTINERI, A., GRADONI, L., CALDEIRA, L., and DAVIDSON, R. N.J. Infect., 1996, 32 (2), 133–137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.